BARDA broadens pharma funding to fight superbugs | Hospital disaster preparedness tools: A systematic review | CDC appoints new safety czar to improve handling of dangerous pathogens | The response to Ebola—Looking back and looking ahead | CDC: Flu vaccine coverage up a bit in 2014-15 | Saudi minister says MERS cases are reducing before haj | Why India is a hotbed of antibiotic resistance and Sweden is not | In key anthrax test, scientist just threw out test tube showing sample was alive (USA Today | Measles outbreak in Democratic Republic of Congo kills 400 | Social vulnerability and Ebola in rural Liberia | Cross-neutralizing antibodies to specific flu strains among middle-aged adults | Malaria MDG target achieved amid sharp drop in cases and mortality | Encouraging results from real-world users of HIV-prevention pill | ECDC: The need for more data and research on MERS | Mapp Biopharma’s Ebola drug gets FDA fast track status | Cardiologist nominated to be next FDA chief | Millions of children’s lives saved as malaria deaths plunge: U.N. | What are the real risks of bioweapons research? | Experimental Ebola vaccine regimen takes new steps under HHS program
See what we’re reading this week at Global Biodefense on topics including the new CDC Safety Czar, lessons learned from Ebola response, and DoD anthrax woes.
BARDA broadens pharma funding to fight superbugs (Science)
Hospital disaster preparedness tools: A systematic review (PLOS)
CDC appoints new safety czar to improve handling of dangerous pathogens (Reuters)
The response to Ebola—Looking back and looking ahead (JAMA)
CDC: Flu vaccine coverage up a bit in 2014-15 (CIDRAP)
Saudi minister says MERS cases are reducing before haj (Reuters)
Why India is a hotbed of antibiotic resistance and Sweden is not (NPR)
In key anthrax test, scientist just threw out test tube showing sample was alive (USA Today)
Measles outbreak in Democratic Republic of Congo kills 400 (NY Times)
Social vulnerability and Ebola in rural Liberia (Resilience System)
Cross-neutralizing antibodies to specific flu strains among middle-aged adults (AFD)
Malaria MDG target achieved amid sharp drop in cases and mortality (WHO/UNICEF)
Encouraging results from real-world users of HIV-prevention pill (Reuters)
ECDC: The need for more data and research on MERS (AFD)
Mapp Biopharma’s Ebola drug gets FDA fast track status (Reuters)
Cardiologist nominated to be next FDA chief (Science)
Millions of children’s lives saved as malaria deaths plunge: U.N. (Reuters)
What are the real risks of bioweapons research? (PopSci)
Experimental Ebola vaccine regimen takes new steps under HHS program (ICT)
